The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2022

Filed:

Jun. 03, 2019
Applicant:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Inventors:

Charles Sawyers, New York, NY (US);

David Ulmert, Brooklyn, NY (US);

Jason Lewis, New York, NY (US);

Michael Evans, New York, NY (US);

Hans Lija, New York, NY (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/10 (2006.01); G01N 33/574 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
A61K 51/1018 (2013.01); A61B 5/4381 (2013.01); A61B 5/4833 (2013.01); A61K 51/1072 (2013.01); G01N 33/57434 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention provides methods of monitoring and measuring tumor-associated free PSA ('fPSA') with antibody polypeptides as an indication of androgen receptor signaling. In a particular embodiment, the methods may be used to assess the efficacy of anti-androgen and/or general anti-cancer treatments. The present invention also provides various methods and compositions relating to antibodies that are specific for tumor-associated or intratumoral fPSA. For example, the present invention provides compositions, including pharmaceutical compositions, comprising anti-fPSA antibodies, or fragments or characteristic portions thereof. The present invention further provides various therapeutic and/or diagnostic methods of using anti-fPSA antibodies and/or compositions.


Find Patent Forward Citations

Loading…